As far as the cellular profile is concerned, inflammation due to IL-1β release appeared to be elevated in the patients with non-MDR-VAP compared to the MDR-VAP patients, probably due to the fact that the non-MDR patients had a more active immune system capable of recruiting immune cells. Here, IL1B is linked to ventilator-associated pneumonia.